RECRUITING

Pneumatic Compression Vs Blood Flow Restriction for Muscle Recovery

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Both BFR and intermittent pneumatic compression are purported to decrease symptoms associated with exercise induced muscle damage (EIMD) that cause delayed onset muscle soreness (DOMS). Blood flow restriction relies on applying pressurized cuffs to the most proximal portion of the limb. Another form of recovery often relied upon is pneumatic compression. The mechanism by which pneumatic compression works is similar to that of a massage, whereby the device progressively increases the pressure on a portion of the limb before releasing and moving further up the limb.The purpose of this study is determine whether BFR or pneumatic compression can be used to decreased DOMS which may indicate enhanced recovery.

Official Title

Comparing the Effects of Pneumatic Compression and Blood Flow Restriction Therapy on Muscle Recovery

Quick Facts

Study Start:2024-01-15
Study Completion:2025-07-01
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06815367

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 30 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT
Inclusion CriteriaExclusion Criteria
  1. * 18-30 years of age
  2. * Recreationally active population
  3. * Women should be on a form of hormonal contraception.
  4. * No current musculoskeletal injuries or pathologies
  5. * Must answer "yes" to all PAR-Q questions.
  1. * Individuals that routinely train trail running
  2. * Discomfort when running
  3. * Deep vein thrombosis
  4. * Blood clots
  5. * Cancerous lesions
  6. * Sensory or mental impairment
  7. * Unstable fractures
  8. * Acute pulmonary edema
  9. * Acute thrombophlebitis
  10. * Acute congestive cardiac failure
  11. * Acute infections
  12. * Episodes of pulmonary embolism
  13. * Wounds, lesions, infection, or tumors
  14. * Bone fractures or dislocations
  15. * Increased venous and lymphatic return
  16. * Answers "no" to any of the PAR-Q screening questions

Contacts and Locations

Study Contact

Bailey McLagan, MS
CONTACT
323-442-2498
mclagan@usc.edu

Study Locations (Sites)

University of Southern California
Los Angeles, California, 90033
United States

Collaborators and Investigators

Sponsor: University of Southern California

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-01-15
Study Completion Date2025-07-01

Study Record Updates

Study Start Date2024-01-15
Study Completion Date2025-07-01

Terms related to this study

Additional Relevant MeSH Terms

  • Delayed Onset Muscle Soreness